ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975

NCI director recognizes work of staff.

October 17, 2003

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005